Farma de Colombia SA   Report issue

For profit Phase 3
Founded: Bogota Colombia (1960)
Status: No NME R&D (1960)

Organization Overview

First Clinical Trial
2013
NCT01850160
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Farma de Colombia SA

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorthalidone (Hygroton) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Other Trials (2)

vitamin (1 trial)

vitamin d (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4